210 related articles for article (PubMed ID: 31487061)
21. Menin regulates Inhbb expression through an Akt/Ezh2-mediated H3K27 histone modification.
Gherardi S; Ripoche D; Mikaelian I; Chanal M; Teinturier R; Goehrig D; Cordier-Bussat M; Zhang CX; Hennino A; Bertolino P
Biochim Biophys Acta Gene Regul Mech; 2017 Apr; 1860(4):427-437. PubMed ID: 28215965
[TBL] [Abstract][Full Text] [Related]
22. Water extract of the fruits of Alpinia oxyphylla inhibits osteoclast differentiation and bone loss.
Ha H; Shim KS; Kim T; Lee CJ; Park JH; Kim HS; Ma JY
BMC Complement Altern Med; 2014 Sep; 14():352. PubMed ID: 25249312
[TBL] [Abstract][Full Text] [Related]
23. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
Lin X; Xiao Y; Chen Z; Ma J; Qiu W; Zhang K; Xu F; Dang K; Qian A
Mol Cell Endocrinol; 2019 Aug; 494():110494. PubMed ID: 31260729
[TBL] [Abstract][Full Text] [Related]
24. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12.
Kameda Y; Takahata M; Komatsu M; Mikuni S; Hatakeyama S; Shimizu T; Angata T; Kinjo M; Minami A; Iwasaki N
J Bone Miner Res; 2013 Dec; 28(12):2463-75. PubMed ID: 23677868
[TBL] [Abstract][Full Text] [Related]
25. Orai1-mediated calcium entry plays a critical role in osteoclast differentiation and function by regulating activation of the transcription factor NFATc1.
Hwang SY; Putney JW
FASEB J; 2012 Apr; 26(4):1484-92. PubMed ID: 22198385
[TBL] [Abstract][Full Text] [Related]
26. Cafestol has a weaker inhibitory effect on osteoclastogenesis than kahweol and promotes osteoblast differentiation.
Fukuma Y; Sakai E; Nishishita K; Okamoto K; Tsukuba T
Biofactors; 2015; 41(4):222-31. PubMed ID: 26154488
[TBL] [Abstract][Full Text] [Related]
27. Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity.
Bate-Eya LT; Gierman HJ; Ebus ME; Koster J; Caron HN; Versteeg R; Dolman MEM; Molenaar JJ
Eur J Cancer; 2017 Apr; 75():63-72. PubMed ID: 28214660
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2.
Dudakovic A; Samsonraj RM; Paradise CR; Galeano-Garces C; Mol MO; Galeano-Garces D; Zan P; Galvan ML; Hevesi M; Pichurin O; Thaler R; Begun DL; Kloen P; Karperien M; Larson AN; Westendorf JJ; Cool SM; van Wijnen AJ
J Biol Chem; 2020 Jun; 295(23):7877-7893. PubMed ID: 32332097
[TBL] [Abstract][Full Text] [Related]
29. Multiple pharmacological inhibitors targeting the epigenetic suppressor enhancer of zeste homolog 2 (Ezh2) accelerate osteoblast differentiation.
Galvan ML; Paradise CR; Kubrova E; Jerez S; Khani F; Thaler R; Dudakovic A; van Wijnen AJ
Bone; 2021 Sep; 150():115993. PubMed ID: 33940225
[TBL] [Abstract][Full Text] [Related]
30. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
[TBL] [Abstract][Full Text] [Related]
31. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.
Tsushima H; Okazaki K; Ishihara K; Ushijima T; Iwamoto Y
Arthritis Res Ther; 2015 Feb; 17(1):31. PubMed ID: 25811130
[TBL] [Abstract][Full Text] [Related]
32. Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα.
Ma Z; Yu R; Zhao J; Sun L; Jian L; Li C; Liu X
Inflamm Res; 2019 Feb; 68(2):157-166. PubMed ID: 30604211
[TBL] [Abstract][Full Text] [Related]
33. Annexin II stimulates RANKL expression through MAPK.
Li F; Chung H; Reddy SV; Lu G; Kurihara N; Zhao AZ; Roodman GD
J Bone Miner Res; 2005 Jul; 20(7):1161-7. PubMed ID: 15940368
[TBL] [Abstract][Full Text] [Related]
34. Regulation of Breast Cancer-Induced Osteoclastogenesis by MacroH2A1.2 Involving EZH2-Mediated H3K27me3.
Kim J; Shin Y; Lee S; Kim M; Punj V; Lu JF; Shin H; Kim K; Ulmer TS; Koh J; Jeong D; An W
Cell Rep; 2018 Jul; 24(1):224-237. PubMed ID: 29972783
[TBL] [Abstract][Full Text] [Related]
35. EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification.
Hemming S; Cakouros D; Isenmann S; Cooper L; Menicanin D; Zannettino A; Gronthos S
Stem Cells; 2014 Mar; 32(3):802-15. PubMed ID: 24123378
[TBL] [Abstract][Full Text] [Related]
36. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities.
Joung YH; Darvin P; Kang DY; Sp N; Byun HJ; Lee CH; Lee HK; Yang YM
PLoS One; 2016; 11(7):e0159891. PubMed ID: 27447722
[TBL] [Abstract][Full Text] [Related]
37. Enhancer of zeste homolog 2-catalysed H3K27 trimethylation plays a key role in acute-on-chronic liver failure via TNF-mediated pathway.
Zhou T; Sun Y; Li M; Ding Y; Yin R; Li Z; Xie Q; Bao S; Cai W
Cell Death Dis; 2018 May; 9(6):590. PubMed ID: 29789597
[TBL] [Abstract][Full Text] [Related]
38. Eosinophil chemotactic factor-L (ECF-L): a novel osteoclast stimulating factor.
Oba Y; Chung HY; Choi SJ; Roodman GD
J Bone Miner Res; 2003 Jul; 18(7):1332-41. PubMed ID: 12854845
[TBL] [Abstract][Full Text] [Related]
39. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
[TBL] [Abstract][Full Text] [Related]
40. High histone acetylation and decreased polycomb repressive complex 2 member levels regulate gene specific transcriptional changes during early embryonic stem cell differentiation induced by retinoic acid.
Lee ER; Murdoch FE; Fritsch MK
Stem Cells; 2007 Sep; 25(9):2191-9. PubMed ID: 17525233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
